• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Codeine should be sold for cough but with tighter restrictions

12th September 2020 by PIP editor Leave a Comment

 

In response to the following article:

 

“GPhC sanction six pharmacies over ‘high volume’ codeine sales”

 

Dear PIP Editor,

 

There is not enough regulation around over the counter codeine and sales are too frequent. Codeine sales should be suitably counselled and monitored.

 

I think, however, that codeine should be sold as a cough remedy but with tighter restrictions. In an internet pharmacy, I have previously worked in, every sale is reviewed and checked against a database of customer information to ensure patients are not making multiple purchases. Identification is also checked. This reduces the risk of abuse or misuse.

 

If community pharmacies followed suit, or if there was a system nationally to support this process then this effective cough remedy could be sold safely.

 

Too many pharmacies sell opiates without effective counselling. In many pharmacies where I have locumed, the staff are accustomed to selling opiates dozens of times a day without advising the patient of the risk of addiction or even questioning if the product is necessary.

 

I do not agree with restricting opiates to prescription supply only. Making these products prescription-only would only cause an increased burden on the NHS.

 

GPs are already pestered into prescribing by patient’s who feel entitled to products readily available over the counter.

 

It is obvious to me that POM status does not solve these issues.

 

Yours etc.

 

Anonymous.

 

The PIP team would love to know your views on over the counter opiates. Answer the questions below and with your permission, we will publish your response to this story as a letter to the editor.

 

We'll use your email address only to get back in touch with you after filling in this form.
We'll use your email address only to get back in touch with you after filling in this form.
We welcome all contributions and personal opinions are encouraged but please do make sure you back up any claims with suitable references.

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  Covid-19 community pharmacy vaccine campaign begins

Filed Under: News Tagged With: codeine, opiates

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

Community pharmacists can identify high-risk asthmatic patients

I have seen people slide into addiction after taking OTC opiates

The ‘ART’ of Scottish community pharmacy is all about data

Admiration for community pharmacy in Scotland

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.